JP2024525665A5 - - Google Patents

Info

Publication number
JP2024525665A5
JP2024525665A5 JP2024501179A JP2024501179A JP2024525665A5 JP 2024525665 A5 JP2024525665 A5 JP 2024525665A5 JP 2024501179 A JP2024501179 A JP 2024501179A JP 2024501179 A JP2024501179 A JP 2024501179A JP 2024525665 A5 JP2024525665 A5 JP 2024525665A5
Authority
JP
Japan
Application number
JP2024501179A
Other languages
Japanese (ja)
Other versions
JPWO2023283092A5 (https=
JP2024525665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/035613 external-priority patent/WO2023283092A1/en
Publication of JP2024525665A publication Critical patent/JP2024525665A/ja
Publication of JPWO2023283092A5 publication Critical patent/JPWO2023283092A5/ja
Publication of JP2024525665A5 publication Critical patent/JP2024525665A5/ja
Pending legal-status Critical Current

Links

JP2024501179A 2021-07-06 2022-06-29 効率的なゲノム編集のための組成物及び方法 Pending JP2024525665A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163218744P 2021-07-06 2021-07-06
US63/218,744 2021-07-06
US202163219623P 2021-07-08 2021-07-08
US63/219,623 2021-07-08
PCT/US2022/035613 WO2023283092A1 (en) 2021-07-06 2022-06-29 Compositions and methods for efficient genome editing

Publications (3)

Publication Number Publication Date
JP2024525665A JP2024525665A (ja) 2024-07-12
JPWO2023283092A5 JPWO2023283092A5 (https=) 2025-07-07
JP2024525665A5 true JP2024525665A5 (https=) 2025-07-07

Family

ID=84800962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501179A Pending JP2024525665A (ja) 2021-07-06 2022-06-29 効率的なゲノム編集のための組成物及び方法

Country Status (6)

Country Link
US (1) US20240228988A1 (https=)
EP (1) EP4367227A4 (https=)
JP (1) JP2024525665A (https=)
AU (1) AU2022306377A1 (https=)
CA (1) CA3224970A1 (https=)
WO (1) WO2023283092A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7657726B2 (ja) 2019-03-19 2025-04-07 ザ ブロード インスティテュート,インコーポレーテッド 編集ヌクレオチド配列を編集するための方法および組成物
CA3174483A1 (en) 2020-03-04 2021-09-10 Flagship Pioneering Innovations Vi, Llc Improved methods and compositions for modulating a genome
DE112021002672T5 (de) 2020-05-08 2023-04-13 President And Fellows Of Harvard College Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
JP2024533311A (ja) 2021-09-08 2024-09-12 フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー ゲノムを調節するための方法及び組成物
KR20240099164A (ko) 2021-09-08 2024-06-28 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 Pah-조절 조성물 및 방법
JP2024534945A (ja) * 2021-09-10 2024-09-26 アジレント・テクノロジーズ・インク 化学修飾を有するプライム編集のためのガイドrna
EP4444362A4 (en) 2021-12-10 2026-04-01 Flagship Pioneering Innovations Vi Llc CFTR COMPOSITIONS AND MODULATION METHODS
WO2023225670A2 (en) 2022-05-20 2023-11-23 Tome Biosciences, Inc. Ex vivo programmable gene insertion
WO2024020587A2 (en) 2022-07-22 2024-01-25 Tome Biosciences, Inc. Pleiopluripotent stem cell programmable gene insertion
EP4665865A1 (en) 2023-02-17 2025-12-24 Anjarium Biosciences AG Methods of making dna molecules and compositions and uses thereof
WO2024178144A1 (en) * 2023-02-22 2024-08-29 Prime Medicine, Inc. Methods and compositions for editing nucleotide sequences
EP4720304A2 (en) * 2023-05-31 2026-04-08 University of Massachusetts Improved modular prime editing with modified effectors and templates
WO2024259051A1 (en) * 2023-06-14 2024-12-19 The Children's Medical Center Corporation Systems and methods for modifying a polynucleotide
WO2025038881A1 (en) * 2023-08-16 2025-02-20 Beam Therapeutics Inc. Prime editing of single base mutations in sickle cell disease
WO2025076306A1 (en) * 2023-10-06 2025-04-10 University Of Massachusetts Prime editors having improved prime editing efficiency
US20250354138A1 (en) 2024-03-15 2025-11-20 Beam Therapeutics Inc. Prime editing of single base mutations in alpha-1 antitrypsin deficiency
WO2025226946A1 (en) * 2024-04-24 2025-10-30 Cedric Francois Methods and compositions for the treatment of androgenic alopecia
WO2025231071A1 (en) * 2024-05-01 2025-11-06 Beam Therapeutics Inc. Compositions and methods for cell conditioning

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019186348A1 (en) * 2018-03-25 2019-10-03 GeneTether, Inc Modified nucleic acid editing systems for tethering donor dna
WO2020033083A1 (en) * 2018-08-10 2020-02-13 Cornell University Optimized base editors enable efficient editing in cells, organoids and mice
KR20210121113A (ko) * 2019-01-31 2021-10-07 빔 테라퓨틱스, 인크. 비-표적 탈아미노화가 감소된 핵염기 편집기 및 핵염기 편집기를 특성규명하기 위한 분석
CN116355966A (zh) * 2019-02-02 2023-06-30 上海科技大学 一种融合蛋白在遗传编辑的用途
JP7657726B2 (ja) * 2019-03-19 2025-04-07 ザ ブロード インスティテュート,インコーポレーテッド 編集ヌクレオチド配列を編集するための方法および組成物
WO2021042047A1 (en) * 2019-08-30 2021-03-04 The General Hospital Corporation C-to-g transversion dna base editors
EP4081635A4 (en) * 2019-12-26 2024-03-27 Agency for Science, Technology and Research Nucleobase editors

Similar Documents

Publication Publication Date Title
JP2024525665A5 (https=)
JP2024533315A5 (https=)
JP2024546996A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13163U (https=)
BY13158U (https=)
BY13175U (https=)
BY13174U (https=)
BY13140U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13137U (https=)
BY13165U (https=)
BY13164U (https=)
BY23963C1 (https=)